Literature DB >> 7904167

High percentages of CD4-positive lymphocytes harbor the HIV-1 provirus in the blood of certain infected individuals.

O Bagasra1, T Seshamma, J W Oakes, R J Pomerantz.   

Abstract

OBJECTIVES: HIV-1 infection of humans leads to states of immunosuppression. Therefore, we sought to determine precise levels of HIV-1 infection of cells in vivo, as these data may assist in the understanding of the pathogenetic processes involved in HIV infection. DESIGN AND METHODS: We have developed an in situ polymerase chain reaction (IS-PCR), which allows amplification of various genetic elements within intact cells. Initial studies using this technique have demonstrated higher levels of HIV-1 provirus in unfractionated peripheral blood mononuclear cells (PBMC) of infected individuals than have been demonstrated in many previous studies using standard PCR techniques. This study describes a combined protocol in which an immunomagnetic bead separation technique is used with IS-PCR to specifically determine cellular reservoirs for HIV-1 and levels of infected cell types in the peripheral blood.
RESULTS: CD4-positive lymphocytes infected with HIV-1 ranged from 0.2 to 69% in the 42 HIV-1-infected patients evaluated. The percentages of HIV-1-infected CD4-positive lymphocytes increased significantly with advancing stages of disease. These procedures also demonstrated that, with the exception of small percentages of infected peripheral blood monocytes, the CD4-positive lymphocyte is clearly the major cellular reservoir for HIV-1 in the peripheral blood.
CONCLUSIONS: These data suggest that, in certain infected individuals, high levels of CD4-positive lymphocytes may harbor the HIV-1 provirus. Thus, the levels of infected lymphocytes are consistent with possible direct effects of HIV-1 on lymphocyte depletion in vivo.

Entities:  

Mesh:

Year:  1993        PMID: 7904167     DOI: 10.1097/00002030-199311000-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  PCR in situ: aspects which reduce amplification and generate false-positive results.

Authors:  I A Teo; S Shaunak
Journal:  Histochem J       Date:  1995-09

2.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 3.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

4.  Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay.

Authors:  M C Re; G Furlini; D Gibellini; M Vignoli; E Ramazzotti; E Lolli; S Ranieri; M La Placa
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

5.  Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cell surface molecule in vivo.

Authors:  B K Patterson; C Goolsby; V Hodara; K L Lohman; S M Wolinsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

Review 6.  Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement.

Authors:  A Kinter; A S Fauci
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

7.  Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.

Authors:  Ziv Sevilya; Ehud Chorin; Orit Gal-Garber; Einat Zelinger; Dan Turner; Boaz Avidor; Gideon Berke; David Hassin
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.